Mr. Mikalai Zahorski Satang Corporation Co., Ltd. (Satang) by Mr. Poramin Insom, Chief Executive Officer and authorized director, entered into a market maker agreement with LLC Fair Expo by Mr
for investment in Original Equipment Manufacturer of cosmetics (new business – Item B.) - - 148.00 14.99% Within 2019 Total 987.24 987.24 987.24 100% Remark * The Company proceeded with the initial
statement for offer for sale of securities and draft prospectus Amount percent and draft prospectus - Item A.) 6. Lending to the Subsidiary for investment in Original Equipment Manufacturer of cosmetics (new
to refinance existing bank loan to reduce finance cost. The Management expected the Bond to be offered to investor within August 2017. EGM approved par split from 5 Baht to 1 Baht and the Company
amount by 61.89 million of previous year by 7.7 percent. The decreased was due mainly to the higher sales and administrative expenses of a subsidiary who is the manufacturer of exhausted pipe in automotive
Myco Biotech company limited is the first manufacturer to produce this potential product for expanding the revenue to the company in the future. 10. Opinion of the Audit Committee and/or the Directors
Transaction and Transaction Size 5.1 General Characteristics of Transaction The Seller, a publicly traded global manufacturer and marketer of differentiated and specialty chemicals, with multiple manufacturing
is accepted by both domestic and international markets as a standard manufacturer of instant products. The investment rationale aligns with the company’s long-term business strategy to diversify its
higher sales and profit of a subsidiary who is the manufacturer of exhausted pipe in automotive industry. 1.10 Profitability For the year ended 31st March 2018, the Company and its subsidiaries had higher
expand the Malaysian market share and retain the existing customers. Moreover, FKRMM was a motorcycle tire and tube manufacturer, therefore its personnel not only has expertise in market distribution but